Del Sette Capital Management LLC Invests $3.25 Million in ARK Genomic Revolution ETF (BATS:ARKG)

Del Sette Capital Management LLC acquired a new stake in ARK Genomic Revolution ETF (BATS:ARKG) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 99,135 shares of the company’s stock, valued at approximately $3,253,000. ARK Genomic Revolution ETF accounts for about 2.9% of Del Sette Capital Management LLC’s investment portfolio, making the stock its 12th largest holding.

Other hedge funds have also recently added to or reduced their stakes in the company. SG Americas Securities LLC increased its holdings in ARK Genomic Revolution ETF by 835.6% in the fourth quarter. SG Americas Securities LLC now owns 213,059 shares of the company’s stock valued at $6,990,000 after buying an additional 190,287 shares in the last quarter. Tower Research Capital LLC TRC purchased a new position in shares of ARK Genomic Revolution ETF during the 3rd quarter worth approximately $2,007,000. International Assets Investment Management LLC increased its stake in shares of ARK Genomic Revolution ETF by 120.1% during the 4th quarter. International Assets Investment Management LLC now owns 107,617 shares of the company’s stock worth $3,280,000 after purchasing an additional 58,715 shares in the last quarter. Barclays PLC increased its stake in shares of ARK Genomic Revolution ETF by 4,817.0% during the 3rd quarter. Barclays PLC now owns 52,120 shares of the company’s stock worth $1,452,000 after purchasing an additional 51,060 shares in the last quarter. Finally, Insight Advisors LLC PA purchased a new position in shares of ARK Genomic Revolution ETF during the 4th quarter worth approximately $972,000.

ARK Genomic Revolution ETF Price Performance

Shares of ARKG traded up $0.17 during mid-day trading on Friday, reaching $23.18. 1,783,082 shares of the company’s stock were exchanged. The stock’s 50-day simple moving average is $28.05 and its 200-day simple moving average is $28.36.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.